Boehringer Ingelheim Press Releases

Press Release Subscription: Signup here to the Boehringer Ingelheim Newsletter to receive press-releases via email.

Information for...

General Use Patients or Carers Health Care Professionals in the US Health Care Professionals outside the US and UK Journalists Jobseekers

PRESS RELEASE

Press Release Overview

Here you can find an overview list of our recent Press Releases.

Read more
PRESS RELEASE 02 Jul 2020 at 15:00

Boehringer Ingelheim Launches External Innovation Hub in China

Read more on
Boehringer Ingelheim Launches External Innovation Hub in China
PRESS RELEASE 25 Jun 2020 at 08:00

Boehringer Ingelheim’s China-developed Classical Swine Fever live vaccine approved

Read more on
Boehringer Ingelheim’s China-developed Classical Swine Fever live vaccine approved
PRESS RELEASE 08 Jun 2020 at 14:00

New consortium EUbOPEN will provide tools to unlock disease biology

Read more on
New consortium EUbOPEN will provide tools to unlock disease biology
PRESS RELEASE 04 Jun 2020 at 08:00

“LastMile” – improving through digital

Read more on
“LastMile” – improving through digital
PRESS RELEASE 29 May 2020 at 13:00

Boehringer Ingelheim receives positive CHMP opinion for a third nintedanib indication in pulmonary fibrosis¹

Read more on
Boehringer Ingelheim receives positive CHMP opinion for a third nintedanib indication in pulmonary fibrosis¹
PRESS RELEASE 25 May 2020 at 17:00

Winners of 2020 BVDzero Case Awards announced

Read more on
Winners of 2020 BVDzero Case Awards announced
PRESS RELEASE 14 May 2020 at 14:00

Boehringer Ingelheim Acquires Northern Biologics’ Preclinical Cancer Antibody Pipeline, Expanding Immuno-oncology Portfolio

Read more on
Boehringer Ingelheim Acquires Northern Biologics’ Preclinical Cancer Antibody Pipeline, Expanding Immuno-oncology Portfolio
PRESS RELEASE 13 May 2020 at 14:00

Boehringer Ingelheim Collaborates with CDR-Life to Develop Antibody Fragment-based Therapeutics for Geographic Atrophy, a Leading Cause of Blindness Worldwide

Read more on
Boehringer Ingelheim Collaborates with CDR-Life to Develop Antibody Fragment-based Therapeutics for Geographic Atrophy, a Leading Cause of Blindness Worldwide
PRESS RELEASE 21 Apr 2020 at 09:00

European Commission approves nintedanib for the treatment of systemic sclerosis-associated interstitial lung disease (SSc-ILD)

Read more on
European Commission approves nintedanib for the treatment of systemic sclerosis-associated interstitial lung disease (SSc-ILD)
PRESS RELEASE 21 Apr 2020 at 08:15

Boehringer Ingelheim puts patient needs first as reflected in the results of the latest “PatientView” survey

Read more on
Boehringer Ingelheim puts patient needs first as reflected in the results of the latest “PatientView” survey
PRESS RELEASE 21 Apr 2020 at 08:00

Aservo^{^®} EquiHaler^{^®} wins Red Dot for outstanding design quality

Read more on
Aservo^{^®} EquiHaler^{^®} wins Red Dot for outstanding design quality
PRESS RELEASE 14 Apr 2020 at 08:00

2020 European PRRS Research Award: Boehringer Ingelheim calls for submissions

Read more on
2020 European PRRS Research Award: Boehringer Ingelheim calls for submissions
PRESS RELEASE 09 Apr 2020 at 11:00

Boehringer Ingelheim Biopharmaceuticals China receives “Facility of the Year” Award

Read more on
Boehringer Ingelheim Biopharmaceuticals China receives “Facility of the Year” Award
PRESS RELEASE 08 Apr 2020 at 10:00

2019 performance: stronger foundation to absorb global effects of COVID-19 pandemic

Read more on
2019 performance: stronger foundation to absorb global effects of COVID-19 pandemic
PRESS RELEASE 08 Apr 2020 at 08:00

Covid Global Support Program

Read more on
Covid Global Support Program
PRESS RELEASE 16 Mar 2020 at 09:00

New uncommon EGFR mutations database published featuring clinical outcomes of NSCLC patients treated with afatinib

Read more on
New uncommon EGFR mutations database published featuring clinical outcomes of NSCLC patients treated with afatinib
PRESS RELEASE 16 Mar 2020 at 08:00

The World Association for Buiatrics and Boehringer Ingelheim announce the 'Ruminant Well-Being Awards’

Read more on
The World Association for Buiatrics and Boehringer Ingelheim announce the 'Ruminant Well-Being Awards’
PRESS RELEASE 28 Feb 2020 at 12:40

Boehringer Ingelheim receives positive CHMP opinion for nintedanib for the treatment of systemic sclerosis-associated interstitial lung disease

Read more on
Boehringer Ingelheim receives positive CHMP opinion for nintedanib for the treatment of systemic sclerosis-associated interstitial lung disease
PRESS RELEASE 27 Feb 2020 at 16:00

Boehringer Ingelheim Enters Discovery Stage Collaboration with Trutino Biosciences to Grow Its Cancer Immunology Portfolio with Novel Cytokine Platform

Read more on
Boehringer Ingelheim Enters Discovery Stage Collaboration with Trutino Biosciences to Grow Its Cancer Immunology Portfolio with Novel Cytokine Platform